Center-Authored Papers

Filters: Author is Storer, Barry  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Whole-Body Irradiation
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM.  2005.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 45(3):502-9. Abstract
Kahl C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B.  2004.  Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(12):826-33. Abstract
Vidarabine
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM.  2005.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 45(3):502-9. Abstract
Vaccine and Infectious Disease Division
McDermott CL, Sandmaier BM, Storer B, Li H, Mager DE, Boeckh MJ, Bemer MJ, Knutson J, McCune JS.  2013.  Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1159-66. Abstract
Treatment Outcome
Sorror ML, Storer B, Storb RF.  2009.  Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(6):757-8.
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.  2005.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.. Blood. 106(8):2912-9. Abstract
Transplantation, Homologous
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.  2005.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.. Blood. 106(8):2912-9. Abstract
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM.  2005.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 45(3):502-9. Abstract
Transplantation, Heterologous
Kahl C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B.  2004.  Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(12):826-33. Abstract
Transplantation Conditioning
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R.  2004.  Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.. Blood. 104(4):961-8. Abstract
Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R.  2004.  Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.. Blood. 104(5):1550-8. Abstract
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM.  2005.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 45(3):502-9. Abstract
Tissue Donors
Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R.  2004.  Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.. Blood. 104(5):1550-8. Abstract
Survival Rate
Sorror ML, Giralt S, Sandmaier BM, DeLima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R.  2007.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.. Blood. 110(13):4606-13. Abstract
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.  2005.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.. Blood. 106(8):2912-9. Abstract
Survival Analysis
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R.  2004.  Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.. Blood. 104(4):961-8. Abstract
Stem Cell Transplantation
Kahl C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B.  2004.  Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(12):826-33. Abstract
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.  2005.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.. Blood. 106(8):2912-9. Abstract
Shared Resources
Pidala J, Vogelsang G, Martin P, Chai X, Storer B, Pavletic S, Weisdorf DJ, Jagasia M, Cutler C, Palmer J et al..  2012.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.. Haematologica. 97(3):451-8. Abstract
Mielcarek M, Storer B, Martin PJ, Forman SJ, Negrin RS, Flowers ME, Inamoto Y, Chauncey TR, Storb R, Appelbaum FR et al..  2012.  Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.. Blood. 119(11):2675-2678. Abstract
Severity of Illness Index
Sorror ML, Giralt S, Sandmaier BM, DeLima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R.  2007.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.. Blood. 110(13):4606-13. Abstract
Sensitivity and Specificity
Sorror ML, Giralt S, Sandmaier BM, DeLima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R.  2007.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.. Blood. 110(13):4606-13. Abstract
Risk Factors
Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R.  2004.  Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.. Blood. 104(5):1550-8. Abstract